Reply to Comment on: Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study

Am J Ophthalmol. 2020 Jul:215:154-155. doi: 10.1016/j.ajo.2019.12.007. Epub 2020 Mar 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Choroidal Neovascularization*
  • Humans
  • Macular Degeneration*
  • Ranibizumab
  • Recombinant Fusion Proteins

Substances

  • Recombinant Fusion Proteins
  • KH902 fusion protein
  • Ranibizumab